Skip to content

Clinical trials

Completed Carcinoma, Renal Cell trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Completed Country / region: South Korea Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20064
20073
20084
20093
20102
20112
20121
20135
20143
20152
20164
20174
20181
20192
20203
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Pfizer5
Seoul National University Hospital5
Merck Sharp & Dohme LLC4
Bayer2
GlaxoSmithKline2
Hoffmann-La Roche2
Yonsei University2
Asan Medical Center1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell46
Carcinoma, Non-Small-Cell Lung6
Carcinoma, Hepatocellular5
Kidney Neoplasms5
Neoplasms5
Carcinoma3
Colorectal Neoplasms3
Neoplasm Metastasis3
Adenocarcinoma2
Breast Neoplasms2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.